William Blair, Sofi
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...
Hosted on MSN3d
CVRx upgraded by William Blair to outperformWilliam Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm ...
Jefferies has recently reduced Allakos Inc (ALLK) stock to Hold rating, as announced on January 17, 2024, according to Finviz. Earlier, on January 16, 2024, Cantor Fitzgerald had reduced the stock ...
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...
Enovix Corp (ENVX) stock saw a modest uptick, ending the day at $10.95 which represents a slight increase of $0.17 or 1.58% from the prior close of $10.78. The stock opened at $10.75 and touched a low ...
William Blair initiated coverage of Cboe Global Markets (CBOE) with a Market Perform rating and no price target The firm does not expect multiple expansion for the shares as zero days to expiration ...
Equities research analysts at William Blair raised their FY2025 earnings per share (EPS) estimates for Lululemon Athletica in a report issued on Monday, January 13th. William Blair analyst S. Zackfia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback